The role of macrophage colony-stimulating factor in patients with acute myocardial infarction: A pilot study

Angiology

Volumn 63, Issue 2, 2012, Pages 127-130

  Novo, Giuseppina ^a   Rizzo, Manfredi ^a   Carruba, Salvatore La ^b   Caruso, Marco ^a   Amoroso, Gisella Rita ^a   Balistreri, Carmela Rita ^a   Coppola, Giuseppe ^a   Evola, Giovanna ^a   Caruso, Calogero ^a   Assennato, Pasquale ^a   Novo, Salvatore ^a   Mancuso, Dario ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Villa Sofia Whitaker Hospital   (Italy)

Author keywords

heart failure; macrophage colony stimulating factor; myocardial infarction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; COLONY STIMULATING FACTOR 1; FIBRINOGEN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; FEMALE; HEART EJECTION FRACTION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; SYSTOLIC DYSFUNCTION;

AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MYOCARDIAL INFARCTION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84856038238     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711409742     Document Type: Article

References (16)

1. Libby P.. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001 ; 104 (3). 365
2. Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol. 1998 ; 31 (7). 1460-1465 (Pubitemid 28273285)
3. Corrado E, Rizzo M, Tantillo R, et al. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5 years follow-up study. Stroke. 2006 ; 37 ( ): 482-486 (Pubitemid 43732010)
4. Rizzo M, Corrado E, Coppola G, Muratori I, Novo G, Novo S.. Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol. Atherosclerosis. 2008 ; 200 (2). 389-395
5. Panteghini M.. Role and importance of biochemical markers in clinical cardiology. Euro Heart J. 2004 ; 25 (14). 1187-1196 (Pubitemid 38891568)
6. Brennan ML, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2003 ; 349 (17). 1595-1604 (Pubitemid 37288567)
7. Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes: implications in plaque rupture. Circulation. 1994 ; 90 (2). 775-778 (Pubitemid 24242744)
8. Ikonomidis I, Lekakis J, Revela I, Andreotti F, Nihoyannopoulos P.. Increased circulating C reactive protein and macrophage colony stimulating factor are complementary predictors of long term outcome in patients with chronic coronary artery disease. Eur Heart J. 2005 ; 26 (16). 1618-1624 (Pubitemid 41389692)
9. Thygesen K, Alpert JS, White HD. Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007 ; 28 (20). 2525-2538
10. Goerke RJ, Carlsson E.. Calculation of right and left cardiac ventricular volumes. Invest Radiol. 1967 ; 2 (5). 360
11. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2000 ; 284 (23). 3043-3045
12. Hoyo Y, Ikeda U, Takahashi M, et al. Increased levels of monocyte derived cytokine in patients with unstable angina. Atherosclerosis. 2002 ; 161: 403-408 (Pubitemid 34219194)
13. Postiglione L, Montagnani S, Ladogana P, et al. Granulocyte macrophage-colony stimulating factor receptor expression on human cardiomyocytes from end-stage heart failure patients. Eur J Heart Fail. 2006 ; 8 (6). 564-570 (Pubitemid 44572962)
14. Oren H, Erbay AR, Balci M, Cehreli S.. Role of novel mediators of inflammation in left ventricular remodeling in patients with acute myocardial infarction: do they affect the outcome of patients?. Angiology. 2007 ; 58 (1). 45-54
15. Yano T, Miura T, Whittaker P, et al. Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair. J Am Coll Cardiol. 2006 ; 47 (3). 626-634 (Pubitemid 43170856)
16. Hohensinner PJ, Rychli K, Zorn G, et al. Macrophage-modulating cytokines predict adverse outcome in heart failure. Thromb Haemost. 2010 ; 103 (2). 435-434